Emerging Ethical Challenges in Manufacturing of Cell-Based Medicines

Area of Science:

• Biomedical Ethics
• Translational Medicine
• Cell Therapy Manufacturing

Background:

• Recent advancements in cell-based medicine manufacturing present novel ethical considerations.
• Existing ethical issues require re-evaluation within the context of contemporary technologies.
• The translational pathway of cell-based medicines involves continuous ethical challenges.

Purpose of the Study:

• To explore new and revisit existing ethical issues in cell-based medicine manufacturing.
• To provide a streamlined overview of ethical challenges by examining them along the translational pathway.
• To underscore the scientific community's responsibility in addressing these ethical concerns.

Main Methods:

• Following the translational pathway of cell-based medicines.
• Examining five central ethical themes: informed consent, cell banking/distribution, governance, representation/equity, and access.
• Synthesizing ethical questions relevant to contemporary cell therapy manufacturing.

Main Results:

• Identified complexities in informed consent processes for cell-based therapies.
• Highlighted intricacies in cell banking and distribution logistics.
• Emphasized the critical role of governance, oversight, representation, diversity, and equity.
• Addressed the responsibility to ensure access to effective cell-based products.

Conclusions:

• Ethical considerations are integral throughout the cell therapy manufacturing translational pathway.
• The scientific community must proactively identify and address ethical challenges.
• A comprehensive understanding of these ethical issues is crucial for responsible innovation in cell-based medicines.